Impact BioMedical Inc.
IBO
$0.45
-$0.0225-4.76%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -438.96% | -469.83% | 118.03% | 43.97% | 34.07% |
| Total Depreciation and Amortization | 0.00% | 16.67% | 100.72% | 25.00% | 200.00% |
| Total Amortization of Deferred Charges | 0.18% | -0.18% | -42.81% | 0.09% | 0.09% |
| Total Other Non-Cash Items | 6,441.27% | 28,984.51% | -353.36% | -95.32% | -90.03% |
| Change in Net Operating Assets | -167.98% | -239.45% | -10.20% | 319.30% | 2,063.41% |
| Cash from Operations | -67.70% | -29.39% | -3.06% | 22.66% | 14.84% |
| Capital Expenditure | -- | -- | 100.00% | 99.66% | 95.37% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 50.00% | -33.33% | 0.00% | 0.00% | -93.94% |
| Cash from Investing | 127.27% | 113.33% | 101.03% | 100.34% | 95.56% |
| Total Debt Issued | -36.68% | -31.62% | -49.43% | -26.83% | -20.69% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 123.17% | 98.43% | 68.03% | -26.83% | -20.69% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 131,500.00% | 199,900.00% | 2,367.00% | 99.22% | 103.13% |